Pharmafile Logo

The Trust Test

- PMLiVE

Healthcare PR agency Spink merges with emotive

Spink’s PR and public affairs expertise will become a part of emotive’s medical and brand offering

Accession Logo

Accession announces investment to support next phase of growth

March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors...

Accession

- PMLiVE

EU considers blocking COVID-19 vaccine exports to the UK

EC president Ursula von der Leyen says she wants "to see reciprocity and proportionality in exports"

- PMLiVE

Merck & Co signs deal with Amathus for neurodegenerative diseases

Collaboration will focus on developing small molecules for undisclosed disease targets

- PMLiVE

UK COVID-19 vaccination drive hit with supply delays over the coming weeks

Weekly vaccine supplies face a 'significant reduction' from 29 March

- PMLiVE

A new era for UK-Japanese scientific research relations

Japan’s biopharmaceutical firms contributed $62.4bn, or 1.3% of GDP, to the country’s economic output in 2019

Out Of Office: The New Normal for Ad Agencies

Covid has made working from home mandatory for most agencies. Life after lockdown may never be the same.

Life Healthcare Communications

- PMLiVE

GSK and Medicago initiate late-stage COVID-19 vaccine study

Plant-based, adjuvanted vaccine candidate received FDA fast track designation in February

- PMLiVE

Create Health announces relaunch under new creativity banner

Healthcare agency announces relaunch 12 months after management buy-out

- PMLiVE

EU announces ‘top-up’ of ten million Pfizer/BioNTech vaccines in Q2

Brings total number of doses of the vaccine to be delivered in Q2 to over 200 million

- PMLiVE

Benefits of AZ COVID-19 vaccine ‘continue’ to outweigh risks, says EMA’s executive director

EU regulator is expected to publish findings from its investigation on Thursday

- PMLiVE

Edging towards success

Evolution tells us to look for small advantages, not big leaps

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links